Stock Events

Stock Events

Longboard Pharmaceuticals 

$60.04
16
+$0.08+0.13% Friday 20:51

Statistics

Day High
59.98
Day Low
59.98
52W High
60.03
52W Low
6.03
Volume
655,798
Avg. Volume
1,805,836
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

27FebExpected
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q3 2024
Q4 2024
-0.7
-0.61
-0.51
-0.42
Expected EPS
-0.627143
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
0Revenue
-54.42MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LBPH. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap22.63B
Biogen is a biotechnology company that develops therapies for neurological and neurodegenerative diseases, competing with Longboard Pharmaceuticals in the neurology market.
Acadia Pharmaceuticals
ACAD
Mkt Cap3.83B
ACADIA Pharmaceuticals specializes in the development of central nervous system therapies, making it a direct competitor to Longboard Pharmaceuticals in the field of neurological disorders.
Alkermes
ALKS
Mkt Cap5.07B
Alkermes plc is involved in the development of drugs for psychiatric and neurological disorders, positioning it as a competitor to Longboard Pharmaceuticals.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotechnology company with a focus on neurological disorders among other areas, competing with Longboard Pharmaceuticals in the biopharmaceutical sector.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap23.49B
Teva Pharmaceutical Industries is a global pharmaceutical company that produces generic and specialty medicines, including treatments for neurological conditions, competing with Longboard Pharmaceuticals.
Jazz Pharmaceuticals
JAZZ
Mkt Cap8.35B
Jazz Pharmaceuticals focuses on developing medicines for neurological disorders, directly competing with Longboard Pharmaceuticals in the neuropharmacology field.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that develops treatments for a wide range of diseases, including neurological disorders, making it a competitor to Longboard Pharmaceuticals.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical corporation with a diverse portfolio that includes treatments for neurological diseases, competing with Longboard Pharmaceuticals.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is a global healthcare company that develops medicines and vaccines for many diseases, including those in the neurological field, competing with Longboard Pharmaceuticals.

About

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical product candidates include LP659 and LP143, which focuses on developing therapies for multiple neurological diseases. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.
Show more...
CEO
Employees
50
Country
US
ISIN
US54300N1037

Listings

0 Comments

Share your thoughts

FAQ

What is Longboard Pharmaceuticals stock price today?▼
The current price of LBPH is $60.04 USD — it has increased by +0.13% in the past 24 hours. Watch Longboard Pharmaceuticals stock price performance more closely on the chart.
What is Longboard Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Longboard Pharmaceuticals stocks are traded under the ticker LBPH.
What is Longboard Pharmaceuticals revenue for the last year?▼
Longboard Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Longboard Pharmaceuticals net income for the last year?▼
LBPH net income for the last year is -54.42M USD.
How many employees does Longboard Pharmaceuticals have?▼
As of April 01, 2026, the company has 50 employees.
In which sector is Longboard Pharmaceuticals located?▼
Longboard Pharmaceuticals operates in the Professional, Scientific, and Technical Services sector.
When did Longboard Pharmaceuticals complete a stock split?▼
Longboard Pharmaceuticals has not had any recent stock splits.